US Exempts Select Indian Specialty Drugs From 100% Tariff, Easing Pressure on Pharma Trade
The United States has exempted select Indian specialty drugs from a proposed 100% tariff, a move that should blunt immediate cost pressure on a critical export segment for Indiaโs pharmaceutical industry. The decision offers relief to manufacturers of high-value medicines while underscoring the continuing sensitivity of trade policy in a sector central to both countriesโ healthcare supply chains.
